Prostate Cancer: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 72 year old man with history of Gleason Score 4+3 =7 adenocarcinoma diagnosed by prostate biopsy after the patient was found to have an elevated PSA of 212.  Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives:

1.Evaluate the pathological and clinical prognostic features for catration resistant adenocarcinoma of the prostate

2.Analyze the potential role of ARV7 expression in circulating tumor cells in prostate cancer

3.Discuss the role of tumor molecular testing in the therapeutic management in patients with Adenocarcinoma of the prostate

This activity was made available on 7/29/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(s) ™ credit is available.

Competencies Addressed

Medical Knowledge (ACGME, AAPA)

Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)